Theravance Biopharma, Inc. (TBPH)

16.86 +0.08 (+0.48%) USD  |  NASDAQ  |  Apr 17, 10:21
More

Theravance Biopharma Quarterly Actual Revenue

Quarterly Actual Revenue Chart

View Quarterly Actual Revenue for TBPH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Quarterly Actual Revenue Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Quarterly Actual Revenue Range, Past 5 Years

View Quarterly Actual Revenue Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Quarterly Actual Revenue Benchmarks

View Quarterly Actual Revenue Benchmarks
Start Trial
Integer Holdings Corp. Upgrade
QuidelOrtho Corp. Upgrade
Catalyst Pharmaceuticals, Inc. Upgrade
Relmada Therapeutics, Inc. Upgrade
Avalo Therapeutics, Inc. Upgrade